Shikun U’binui sells Road 6 stake for NIS 773m.

Capital gain of NIS 85 million will be reported on the sale.

September 13, 2011 23:27
1 minute read.
Traffic crawls in both directions on the Tel Aviv-

traffic jam highway 1 311. (photo credit: Ariel Jerozolimski)

Shikun u’Binui Holdings, controlled by Shari Arison, has sold 24.5 percent of Road 6 (the Trans-Israel Highway) franchisee Derech Eretz Highways to Israel Infrastructure Fund for NIS 773 million.

Shikun u’Binui will report a capital gain of NIS 85 million on the sale.

Be the first to know - Join our Facebook page.

Shikun u’Binui and IIF currently own Derech Eretz in equal shares. The sale reduces Shikun u’Binui’s stake in the company to 25.5%. Shikun u’Binui did not sell its 24.5% stake in Derech Eretz Highways Management Ltd., which operates the Road 6 toll road, and is waiting for permission to increase its stake to 35%.

The deal reflects a company value of NIS 3 billion for Derech Eretz. The sale is part of IIF’s effort to block rival Noy Infrastructures and Energy Fund's acquisition of 49% of the government’s rights in Derech Eretz for NIS 1.39 billion. Shikun u’Binui said that the price tag was based on Derech Eretz’s value in the Noy Fund deal.

Sources inform Globes that Noy Fund tried to buy Shikun u’Binui’s stake in the company, but failed to strike a deal.

IIF promised that it would try to have Shikun u’Binui or its affiliates carry out future roadworks on Road 6 at market prices in accordance to an agreed-upon mechanism.

Shikun u’Binui CEO Ofer Kotler said, “We successfully completed the planning, financing, and construction of Road 6 - giving substantial added value to Shikun u’Binui. Road 6 has become an income-producing property, and in line with the company’s strategy, we decided to sell our rights in it for NIS 773 million, reflecting a return of 8%.”

Shikun u’Binui's share price rose 6.7% by mid-afternoon to NIS 6.42, giving a market cap of NIS 2.6 billion. Harel’s share price rose 2% to NIS 138.50, giving a market cap of NIS 2.9 billion.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection


Israel Weather
  • 15 - 27
    Beer Sheva
    17 - 22
    Tel Aviv - Yafo
  • 15 - 23
    14 - 22
  • 18 - 32
    16 - 28